[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600133":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Heart Failure with a Preserved Ejection Fraction (HFpEF)",null,"Subjects with diagnosed Heart failure with a preserved ejection fraction (HFpEF), non-obstructive Coronary Artery Disease (CAD), and have documented CMD.",[13],"Diagnostic Test: Cardiovascular Magnetic Resonance (CMR)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","Cardiovascular Magnetic Resonance (CMR)","Patients will consent to undergo a 50-minute non-invasive stress perfusion CMR.",[9],[21],{"name":22,"affiliation":5,"role":23},"Claire Raphael, M.B.B.S., Ph.D.","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Diana Albers","CONTACT","507-255-6884","albers.diana2@mayo.edu",[31],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-92.4699,44.02163,{"lat":42,"lon":41},[45,46],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":23,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Claire E. Raphael","Principal Investigator","100600133","a-study-of-cs-reducer-for-symptomatic-heart-failure-with-hfpef-and-cmd-100600133",false,"NCT07093528","A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD","CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)","Inclusion Criteria:\n\n* Age ≥18\n* Enrollment in main CS-reducer HFPEF study IRB# 25-002292\n\nExclusion Criteria:\n\n* Metal implants that are not suitable for MRI\n* Inability or unwillingness of individual to give written informed consent.","ALL","18 Years",{"count":60,"type":61},25,"ESTIMATED","OBSERVATIONAL","To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)",[65,66],"Heart Failure With Preserved Ejection Fraction","Coronary Microvascular Dysfunction","2026-02-24",{"date":69,"type":70},"2026-02-27","ACTUAL",{"date":72,"type":70},"2025-10-16",{"date":74,"type":61},"2027-08",{"name":5,"class":6},1]